EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.4.1.206 | more |
essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids |
Rattus norvegicus |
? |
- |
? |
2.4.1.206 | more |
the enzyme is expressed in two distinct phases during the zebrafish embryogenesis. The early phase extends from late blastulation to the completion of epiboly, during which the expression occurs in the superficial layer of the embryos. The second phase of expression starts during mid-segmentation and persists until day 3, during which the expression occurs prominently in the developing lens. Hedgehog signaling is required for the Lc3 synthase expression in embryonic lens |
Danio rerio |
? |
- |
? |
2.4.1.206 | more |
the enzyme synthesizes the key intermediate lactosyltriosylceramide for lacto- and neolactoglycolipids. The large increase in the activity of Lc3 synthase appears to regulate the levels of other neolacto glycolipids, such as Lc3cer, nLc4Cer, nLc6Cer, disialosyl-nLc4Cer and Le(x)-glycolipids |
Mus musculus |
? |
- |
? |
2.4.1.206 | more |
beta3Gn-T2 associates with beta3Gn-T8 in vivo |
Homo sapiens |
? |
- |
? |
2.4.1.206 | more |
Lc3 synthase utilizes a variety of galactose-terminated glycolipids as acceptors by establishing a glycosidic bond in the beta-1,3-linkage to GlcNaAc to extend the lacto- and neolacto-series gangliosides |
Mus musculus |
? |
- |
? |
2.4.1.206 | more |
Lc3 synthase utilizes a variety of galactose-terminated glycolipids as acceptors by establishing a glycosidic bond in the beta-1,3-linkage to GlcNaAc to extend the lacto- and neolacto-series gangliosides |
Mus musculus C57BL/6 |
? |
- |
? |
2.4.1.206 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-(1-4)-beta-D-glucosyl-(1-1)-ceramide |
- |
Homo sapiens |
UDP + N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide |
- |
? |
2.4.1.206 | UDP-N-acetyl-D-glucosamine + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-1,4-beta-(sialyl-alpha-2,3)-D-galactosyl-1,4-beta-D-glucosylceramide |
- |
Homo sapiens |
UDP + N-acetyl-D-glucosaminyl-1,3-beta-D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-1,4-beta-(sialyl-alpha-2,3)-D-galactosyl-1,4-beta-D-glucosylceramide |
- |
? |
2.4.1.206 | UDP-N-acetyl-D-glucosamine + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-1,4-beta-(sialyl-alpha-2,3)-D-galactosyl-1,4-beta-D-glucosylceramide |
- |
Mus musculus |
UDP + N-acetyl-D-glucosaminyl-1,3-beta-D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-1,4-beta-(sialyl-alpha-2,3)-D-galactosyl-1,4-beta-D-glucosylceramide |
- |
? |
2.4.1.206 | UDP-N-acetyl-D-glucosamine + D-galactosyl-1,4-beta-D-glucosylceramide |
- |
Rattus norvegicus |
UDP + N-acetyl-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide |
- |
? |